Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1297-1308 of 2022 results
Page 109 of 169
Key Publications January 27, 2014

Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk.

Atherosclerosis 2013;230:347-53

Damasceno NR, Sala-Vila A, Cofán M, Pérez-Heras AM, Fitó M, Ruiz-Gutiérrez V, Martínez-González MÁ, Corella D, Arós F, Estruch R, Ros E
Abdominal Obesity/Body Fat Distribution Lipids/Lipoproteins Nutrition
Key Publications January 27, 2014

Nuts and not olive oil decrease small and dense LDL: Results from the PREDIMED Study.

Atherosclerosis 2013;231:59-60

Zampelas A
Lipids/Lipoproteins Nutrition
Key Publications January 24, 2014

Abdominal obesity with hypertriglyceridaemia, lipoprotein(a) and apolipoprotein A-I determine marked cardiometabolic risk.

Eur J Clin Invest 2013;43:1129-39

Onat A, Can G, Ornek E, Sansoy V, Aydın M, Yüksel H
Abdominal Obesity/Body Fat Distribution Cardiometabolic Risk Lipids/Lipoproteins
Key Publications January 23, 2014

Unraveling the complexities of the HDL lipidome.

J Lipid Res 2013;54:2950-63

Kontush A, Lhomme M, Chapman MJ
Inflammation Lipids/Lipoproteins
Key Publications January 17, 2014

Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.

Am J Cardiol 2013;112:1063-8

Tanaka F, Makita S, Onoda T, Tanno K, Ohsawa M, Itai K, Sakata K, Omama S, Yoshida Y, Ogasawara K,Ogawa A, Ishibashi Y, Kuribayashi T, Okayama A, Nakamura M, Iwate-Kenco Study Group
Acute Coronary Syndromes Lipids/Lipoproteins
Key Publications January 17, 2014

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Circulation 2013;128:1504-12

Boekholdt SM, Arsenault BJ, Hovingh GK, Mora S, Pedersen TR, Larosa JC, Welch KM, Amarenco P, Demicco DA, Tonkin AM, Sullivan DR, Kirby A, Colhoun HM, Hitman GA, Betteridge DJ, Durrington PN, Clearfield MB,Downs JR, Gotto AM Jr, Ridker PM, Kastelein JJ
Epidemiology Lipids/Lipoproteins
Key Publications January 17, 2014

Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.

J Am Coll Cardiol 2013;62:1396-8

Gibbons GH, Shurin SB, Mensah GA, Lauer MS
Hypertension Lipids/Lipoproteins
Key Publications January 15, 2014

Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age: The ARIC Study.

Am J Epidemiol 2013;178:1076-84

Whelton SP, Roy P, Astor BC, Zhang L, Hoogeveen RC, Ballantyne CM, Coresh J
Age Inflammation Lipids/Lipoproteins
Key Publications January 15, 2014

Skeletal muscle triacylglycerol hydrolysis does not influence metabolic complications of obesity.

Diabetes 2013;62:3350-61

Sitnick MT, Basantani MK, Cai L, Schoiswohl G, Yazbeck CF, Distefano G, Ritov V, Delany JP, Schreiber R, Stolz DB, Gardner NP, Kienesberger PC, Pulinilkunnil T, Zechner R, Goodpaster BH, Coen P, Kershaw EE
Insulin Resistance Lipids/Lipoproteins Obesity
Key Publications January 14, 2014

Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.

Diabetes Care 2013;36:3297-304

Shi L, Ye X, Lu M, Wu EQ, Sharma H, Thomason D, Fonseca VA
Diabetes Insulin Resistance Lipids/Lipoproteins
Key Publications January 13, 2014

Improved plasma FFA/insulin homeostasis is independently associated with Improved glucose tolerance after a 1-year lifestyle intervention in viscerally obese men.

Diabetes Care 2013;36:3254-61

Borel AL, Boulet G, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, Poirier P, Carpentier AC, Després JP
Abdominal Obesity/Body Fat Distribution Insulin Resistance Lipids/Lipoproteins
Key Publications January 9, 2014

Pharmacotherapies for lipid modification: beyond the statins.

Nat Rev Cardiol 2013;10:560-70

Gotto AM Jr, Moon JE
Lipids/Lipoproteins
of 169